GenSight Biologics
gene therapy retinal diseases
- B2B
About GenSight Biologics
development of gene therapies using mitochondrial targeting and optogenetics to treat neurodegenerative retinal diseases and restore vision
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- paris, Île-de-France, France
- Founded
- 2013
- Revenue
- €1KFY2025, filed accounts, INPI
- Website
- gensight-biologics.com
GenSight Biologics at a glance
GenSight Biologics is a B2B company in the Biotechnology Research industry, headquartered in paris, Île-de-France, France.
GenSight Biologics was founded in 2013.
GenSight Biologics has 11–50 employees.
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
Selling to companies like GenSight Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies